Royalty Pharma plc (NASDAQ: RPRX) is -1.35% lower on its value in year-to-date trading and has touched a low of $25.20 and a high of $31.66 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The RPRX stock was last observed hovering at around $27.54 in the last trading session, with the day’s gains setting it 0.17%.
Currently trading at $27.71, the stock is -2.34% and -0.86% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.82 million and changing 0.62% at the moment leaves the stock -2.00% off its SMA200. RPRX registered 5.52% gain for a year compared to 6-month loss of -8.46%.
The stock witnessed a -0.07% gain in the last 1 month and extending the period to 3 months gives it a 2.21%, and is -1.95% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 1.49% over the week and 1.67% over the month.
Royalty Pharma plc (RPRX) has around 89 employees, a market worth around $12.42B and $2.24B in sales. Current P/E ratio is 18.44 and Fwd P/E is 6.31. Profit margin for the company is 30.07%. Distance from 52-week low is 9.96% and -12.46% from its 52-week high. The company has generated returns on investments over the last 12 months (4.78%).
The EPS is expected to shrink by -11.85% this year.
Royalty Pharma plc (RPRX) Top Institutional Holders
625.0 institutions hold shares in Royalty Pharma plc (RPRX), with institutional investors hold 83.66% of the company’s shares. The shares outstanding are 446.69M, and float is at 382.30M with Short Float at 3.84%. Institutions hold 72.74% of the Float.
The top institutional shareholder in the company is MORGAN STANLEY with over 44.13 million shares valued at $1.16 billion. The investor’s holdings represent 9.8375% of the RPRX Shares outstanding. As of 2024-06-30, the second largest holder is VANGUARD GROUP INC with 38.02 million shares valued at $1.0 billion to account for 8.4754 of the shares outstanding. The other top investors are FMR LLC which holds 27.89 million shares representing 6.2161% and valued at over $735.37 million, while BLACKROCK INC. holds 5.1307 of the shares totaling 23.02 million with a market value of $606.97 million.
Royalty Pharma plc (RPRX) Insider Activity
The most recent transaction is an insider sale by RIGGS RORY B, the company’s Director. SEC filings show that RIGGS RORY B sold 235,200 shares of the company’s common stock on Jan 02 ’24 at a price of $28.52 per share for a total of $6.71 million. Following the sale, the insider now owns 0.25 million shares.
Royalty Pharma plc disclosed in a document filed with the SEC on Jan 03 ’24 that RIGGS RORY B (Director) sold a total of 199,098 shares of the company’s common stock. The trade occurred on Jan 03 ’24 and was made at $27.79 per share for $5.53 million. Following the transaction, the insider now directly holds 55801.0 shares of the RPRX stock.
Still, SEC filings show that on Jan 04 ’24, RIGGS RORY B (Director) disposed off 35,702 shares at an average price of $27.55 for $0.98 million. The insider now directly holds 20,099 shares of Royalty Pharma plc (RPRX).
